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Herpes Simplex Virus–Specific T Cells Infiltrate the
Cornea of Patients with Herpetic Stromal Keratitis:
No Evidence for Autoreactive T Cells
Georges M. G. M. Verjans,1,2 Lies Remeijer,1 Cornelia M. Mooy,3 and
Albert D. M. E. Osterhaus2
PURPOSE. Herpetic stromal keratitis (HSK) is a T-cell–mediated inflammatory disease initiated by a
herpes simplex virus (HSV) infection of the cornea. Recently, studies in the HSK mouse model have
shown that the immunopathogenic T cells are directed against the HSV protein UL6 cross-reacting
with an unknown corneal autoantigen. Whether this type of autoimmunity plays a role in human
HSK was analyzed.
METHODS. T-cell lines (TCLs) were generated from corneal buttons of 12 patients with different
clinical stages of HSV-induced necrotizing stromal keratitis (n 5 9) or immune stromal keratitis
(n 5 3). The initiating virus was identified by polymerase chain reaction and immunohistology
performed on the corneal buttons. Peripheral blood mononuclear cells (PBMCs) were isolated, and
B cell lines (BLCLs) were generated by transformation with Epstein-Barr virus. Proliferative re-
sponses of these intracorneal TCLs were determined by culturing T cells with autologous BLCLs
infected with HSV-1, HSV-2, wild-type vaccinia virus (VV-WT), or VV expressing HSV-1 UL6
(rVV-UL6). Alternatively, T cells were incubated with PBMCs pulsed with human cornea protein
extract.
RESULTS. Irrespective of clinical diagnosis or treatment, T cells were recovered from the corneal
buttons of all the 12 HSK patients. The intracorneal TCLs of 9 of the 12 HSK patients showed
HSV-specific T-cell reactivity. In none of the TCLs, T-cell reactivity against HSV-1 UL6 or human
corneal antigens was detected.
CONCLUSIONS. These data suggest that the potentially immunopathogenic intracorneal T-cell re-
sponse in HSK patients is directed to the initiating virus and not to a human corneal autoantigen
or HSV-1 UL6. (Invest Ophthalmol Vis Sci. 2000;41:2607–2612)
Herpes simplex virus (HSV) infections of the cornea canelicit the development of herpetic stromal keratitis(HSK). HSK is a sight-threatening disease in which
tissue destruction, edema, and corneal scarring are the result of
an inflammatory response in the corneal stroma. Current
knowledge on the immunopathogenesis of HSK is primarily
based on studies performed in the experimental mouse model
for HSK that closely mimics necrotizing stromal keratitis in
humans. In the HSK mouse model, CD41 T helper 1 (Th1) cells
have been demonstrated to play a pivotal role in this local
immunopathogenic response.1,2 The other cell types involved
are Langerhans cells (LCs),3 macrophages, and, notably, poly-
morphonuclear neutrophils (PMNs).4,5 The nature of the anti-
gens recognized by these immunopathogenic cornea-infiltrat-
ing T cells is a matter of debate. A long-standing assumption has
been that the intracorneal T-cell response in HSK is directed to
HSV-encoded antigens.6 Recently, however, studies in the HSK
mouse model have provided evidence that HSK is an HSV-
induced autoimmune disease.7,8 HSK could be induced by
CD41 T cells directed to an epitope derived from the HSV-1
capsid protein UL6, that cross-reacts with an epitope of an
antigen uniquely expressed in the murine cornea.8
Recently, we have demonstrated the presence of HSV-
specific CD41 Th0-like cells in corneas of two patients with
necrotizing ulcerative HSK. In this study no reactivity to human
corneal antigens could be detected.9 Nevertheless, autoreac-
tive T cells may still be involved in clinically distinct HSK
entities. In the present study we determined the antigen spec-
ificity of cornea-infiltrating T cells, obtained from 12 patients
with different clinical forms of HSK. T-cell reactivity was tested
toward the HSV serotypes 1 and 2, recombinant HSV-1 UL6,
and a soluble human corneal protein extract.
METHODS
Clinical Materials and Reagents
Corneal buttons and peripheral blood mononuclear cells
(PBMCs) were obtained from 12 patients, with HSV-induced
necrotizing stromal keratitis (patients 1 through 9) or immune
stromal keratitis (patients 10 through 12), after therapeutic
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penetrating keratoplasty. HSK classification, and quiescent dis-
ease for at least 6 months or active disease, was defined on the
basis of clinical criteria.10 The characteristics, diagnosis, and
preoperative treatment of the patients studied are listed in
Table 1. Patient 12 was transplanted because of a corneal graft
rejection due to a necrotizing ulcerative HSK, and patients 1
and 2 have been described previously.9 Isolation of PBMCs and
the generation of B cell lines (BLCLs), by transformation with
Epstein-Barr virus, were performed as described previously.9
Virus stocks of the MacIntyre strain of HSV-1 (American Type
Culture Collection [ATCC] VR-539) and the MS strain of HSV-2
(ATCC VR-540) were generated and titrated in Vero cells.
Recombinant vaccinia virus (VV) rVV-UL6 expressing the
HSV-1 UL6 gene (strain 17) has been described and kindly
provided by Arvind H. Patel (MRC Virology Unit, Institute of
Virology, Glasgow, UK).11 Virus stocks of the rVV-UL6 and the
wild-type strain WR (ATCC VR-1354) were generated and ti-
tered on RK13 cells (ATCC CCL-37). Protein was extracted
from whole human corneas (n 5 12) and donated for trans-
plantation but found unacceptable because of senile changes
of the endothelium, by sonification of a Tris-buffered cornea
tissue lysate as described previously for the generation of a
soluble murine cornea protein extract.7,12 The present study
was performed according to the Declaration of Helsinki, and
informed consent was obtained from all patients.
Immunohistochemistry
Corneal buttons, obtained within 1 hour after surgery, were
divided in two equal parts for immunohistologic analysis and
T-cell recovery. One quarter of the cornea was snap-frozen in
optimal cutting tissue, and one quarter was fixed with formalin
and embedded in paraffin. Routine histopathology (hematoxy-
lin/eosin and periodic acid–Schiff staining) and immunoperox-
idase staining were performed on cryostat and paraffin sections
as described previously.13 Mouse anti-human monoclonal anti-
bodies (MAbs) were used as primary antibodies. The following
MAbs were used as recommended by the supplier: anti-CD3
(Dako, Glostrup, Denmark), anti-CD4 and -CD8 (Becton–Dick-
inson, San Diego, CA), and anti–HSV-1 (Dako). Peroxidase-
labeled polyclonal rabbit anti-mouse IgG antibody (Dako) was
used as secondary antibody and visualized using diaminoben-
zidine or 3-amino-9-ethyl carbazole (Sigma, St. Louis, MO).13
DNA Extraction and Polymerase Chain
Reaction Analyses
The surplus half of the corneal specimens was minced and
treated with collagenase essentially as described previously.9
DNA was isolated from one-fourth part of the corneal cell
suspension lysed in a guanidine isothiocyanate buffer using
Celite solution (Jansen Chemika, Beers, Belgium) according to
the method of Boom et al.14 The polymerase chain reaction
(PCR) primers and conditions for detection of HSV type 1 and
2 and varicella zoster virus specific DNA after Southern blot
analysis have been described previously.15
Cornea-Derived T-Cell Lines
Cornea-derived T-cell lines (TCLs) were generated from the
remaining corneal cell suspension as described previously.9
After one round of mitogenic stimulation, using phytohemag-
glutinin-L (PHA-L; Boehringer–Mannheim, Mannheim, Ger-
many) and allogeneic feeder cells, the intracorneal TCLs were
frozen in aliquots at 2135°C. Control experiments with cor-
neas histologically devoid of infiltrating T cells did not result in
the generation of TCLs, indicating that the method applied
facilitates the recovery and outgrowth of T cells compartmen-
talized to the cornea (data not shown). The TCLs were char-
acterized for cell surface expression of CD3, CD4, and CD8 by
triple color flowcytometry using fluorescein isothiocyanate
(FITC)–, RPE-, and R-Phycoerythrin (RPE)-Cy5–conjugated
MAbs, respectively (Dako).
T-Cell Proliferation Assays
Autologous BLCLs were infected with HSV-1 and HSV-2 at a
multiplicity of infection (MOI) of approximately 5 at 37°C for
TABLE 1. Characteristics of HSK Patients Included in the Present Study
Patient Sex* Age† Diagnosis
Disease
Status
HSV-1
PCR on
Cornea‡
Time Since
Keratitis First
Diagnosed§
Time Since
Last
Recurrence§
Topical
Preoperative
Treatment
Steroids Acyclovir
1 M 51 Necrotizing stromal keratitis Active 1 352 1.5 No Yes
2 M 60 Necrotizing stromal keratitis Active 1 480 0 Yes Yes
3 M 71 Necrotizing stromal keratitis Active 1 4 0 Yes Yes
4 M 57 Necrotizing stromal keratitis Active 1 104 0 Yes Yes
5 M 68 Necrotizing stromal keratitis Active 1 240 0 No No
6 F 90 Necrotizing stromal keratitis Active 1 235 0 No No
7 M 73 Necrotizing stromal keratitis Quiescent 1 80 11 Yes Yes
8 F 31 Necrotizing stromal keratitis Active 2 66 1.5 Yes No
9 F 74 Necrotizing stromal keratitis Quiescent ND 243 17 ? ?
10 F 81 Immune stromal keratitis Quiescent 1 309 13 Yes No
11 M 61 Immune stromal keratitis Active 2 50 1 No No
12 F 64 Immune stromal keratitis Quiescent 2 143 37 No No
* M, male; F, female.
† Age in years.
‡ 1 or 2, positive or negative HSV-1–specific PCR product detected. ND, not done. ?, unknown treatment.
§ Time in months. Times since last recurrence means time lapse since presentation of active disease in months, whereas active disease is
defined as visible stromal infiltration with edema. In the patients with a time lapse of 1–1.5 months, patients 1, 8, and 11, the cornea was still
showing evident cellular infiltration. Impending perforation made penetrating keratoplasty neccessary.
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20 hours. The virus- and mock-infected cells were washed and
UV-irradiated (2.5 3 1022 mW/mm2). Alternatively, BLCLs
were infected with the rVVs at an MOI of approximately 5 for
20 hours and fixed with 1% paraformaldehyde as described
previously.16 The level of infection of the BLCLs with the
respective viruses was determined by flowcytometry. The ex-
pression of HSV-1 UL6 in rVV-UL6–infected BLCLs was dem-
onstrated using a rabbit anti-UL6 serum (2C2)11 and, subse-
quently, FITC-conjugated swine anti-rabbit serum (Dako). As
for all viruses, approximately 70% to 90% of the BLCLs were
shown to be infected (Fig. 1). T cells (3 3 104/well), removed
from culture at days 10 to 12 after one mitogenic stimulation,
were cultured in triplicate together with virus- or mock-in-
fected BLCLs (2 3 104/well) in 96-well round-bottomed plates
in 150 ml complete medium at 37°C in a CO2 incubator.
Complete medium consisted of RPMI 1640 (GIBCO–BRL,
Breda, The Netherlands) supplemented with 10% heat-inacti-
vated pooled human serum and antibiotics. Because of the
limited ability of BLCLs to process and present exogenous
antigens to T cells, T-cell reactivity to human soluble cornea
protein extract (HuSoCo; at final protein concentrations of 50
and 100 mg/ml) was performed using 105 autologous PBMCs
(UV-irradiated) as antigen-presenting cells (APCs). The cells
were cultured for 72 hours and pulsed with 0.5 mCi [3H]-
thymidine over the last 18 hours of culture. The cells were
harvested and the incorporated radioactivity was determined
in a b-scintillation counter. Proliferation was considered posi-
tive when stimulation indices (counts per minute [cpm] incor-
porated in response to antigen/cpm incorporated in response
to control) were more than 4. T-cell reactivity to all antigens
tested for was assayed simultaneously, and PHA-L (1 mg/ml)
was included as positive control for T-cell proliferation. The
assays were performed at least two times, and the SD was
always less than 30% of the mean counts per minute.
RESULTS
Immunohistochemistry on Corneas
of HSK Patients
Diagnostic analyses were performed on corneal buttons, ob-
tained after therapeutic penetrating keratoplasty, from 12 pa-
tients with necrotizing stromal keratitis (patients 1 through 9)
or immune stromal keratitis (patients 10 through 12).10 All
patients had a history of recurrent episodes of HSV-1–induced
stromal keratitis (Table 1). The corneal histopathology ob-
served in the HSK patients (Fig. 2A) included granulomatous
reactions at the level of Descemet’s membrane (Figs. 2B and
2C), suppurative keratitis with edema (Figs. 2D and 2E), reac-
tive hyperplasia of the epithelium, and breakdown of Bow-
man’s layer (Figs. 2F and 2G). A mononuclear cell infiltrate was
observed in the corneas of all patients and consisted predom-
inantly of CD41 T cells (Fig. 2G).
PCR analyses revealed the presence of HSV-1 DNA in 8 of
11 corneas analyzed, implicating HSV-1 as initiating the disease.
HSV-1 DNA–positive corneas were mainly obtained from pa-
tients with fulminant necrotizing stromal keratitis (Table 1).
Evidence for an ongoing intracorneal HSV-1 infection was only
found in patient 5, demonstrated by the presence of HSV-1–
infected keratocytes (Fig. 2E).
Antigen Specificity of Cornea-Derived TCLs from
HSK Patients
We have recently developed a protocol that enables the recov-
ery and expansion of in vivo activated corneal infiltrating T
cells from corneal buttons of HSK patients.9 This method
facilitated the generation of intracorneal TCLs from all 12 HSK
patients studied. All TCLs consisted predominantly of CD31 T
cells and the ratio of CD41and CD81 T cells varied interindi-
vidually. Interestingly, the TCLs of 2 patients with quiescent
necrotizing stromal keratitis consisted almost exclusively of
CD41 T cells (patients 7 and 9; Table 1). The reactivity of the
cornea-derived TCLs toward the triggering virus was analyzed
in T-cell proliferation assays using mock-, HSV-1–, and HSV-2–
infected autologous BLCLs as APCs. The intracorneal TCLs of 9
of 12 patients showed HSV-specific T-cell reactivity (Table 2).
Illustrative for the high sequence homology between the HSV
serotypes, the majority of these TCLs recognized both HSV-1–
and HSV-2–infected BLCLs. In the case of patient 8, however,
the HSV-specific intracorneal T-cell response was restricted to
HSV-2.
To test the hypothesis that an HSV-induced autoreactive
intracorneal T-cell response is involved in the immunopatho-
genesis of HSK in humans, the reactivity of the TCLs to recom-
binant HSV-1 UL6 and a HuSoCo protein extract was deter-
mined. In repeated experiments, none of the TCL showed
significant responses to HSV-1 UL6 or human corneal antigens
(Table 2).
DISCUSSION
HSV infection of the cornea can result in the development of
stromal keratitis, a leading infectious cause of blindness world-
wide. The adult cornea is an ocular tissue without constitutive
lymphoid components. Therefore, any intracorneal T cell
found in HSK patients must have migrated into the cornea
upon infection and subsequent inflammation. Experimental
FIGURE 1. Flowcytometric analysis of BLCLs infected with wild-type
(dashed line) and rVV expressing HSV-1 UL6 (solid line) for the
expression of HSV-1 UL6. The x axis and y axis indicate the fluores-
cence intensity and relative cell number, respectively. For both cell
populations, staining with 1% normal rabbit serum resulted in a similar
histogram as for wild-type VV–infected B cells (data not shown). FL1-H,
Anti-UL6 FITC fluorescence intensity.
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HSK animal models have been developed to investigate the
immunopathogenesis of HSK. Based on these studies, HSK is
considered to represent an immunopathologic reaction in the
corneal stroma coordinated by CD41 Th1 cells.1,2
Although the processes orchestrated by cornea-infiltrating
CD41 T cells have been studied extensively, the target antigens
recognized remain unclear. Given the involvement of HSV in
the etiology of HSK, HSV antigens are the most likely candi-
dates. To address this notion we analyzed the antigen specific-
ity of cornea-infiltrating T cells in 12 patients with HSV-induced
stromal keratitis. After one round of mitogenic stimulation,
cornea-derived TCLs were successfully generated from corneas
FIGURE 2. Macroscopic, histologic, and immunohistologic examination of corneas from patients with HSK. (A) Central corneal ulcer with
descemetocele and impending perforation of the cornea of patient 5. (B, C) Central view of keratectomy specimen of patient 1 showing stromal
infiltration of inflammatory cells and a florid granulomatous reaction with focal rupture of Descemet’s membrane (Dm) (B; periodic acid–Schiff
[PAS] stained; magnification, 3100). Inset: Higher magnification of then multinucleated giant cell (arrow) protruding through this rupture (C; PAS
stained; magnification, 3400). (D) Paracentral view of keratectomy specimen of patient 5 shows (adjacent to the ulcer) a deep stromal defect with
edema and infiltration of PMNs (arrowhead) reaching up to Dm (HE staining; magnification, 3200). (E) Immunohistochemical staining for HSV-1
antigens demonstrating HSV antigens in stromal keratocytes (arrowhead) in the corresponding section of the cornea of patient 5 (hematoxylin
counterstained; magnification, 3400). (F) Central view of keratectomy specimen of patient 6 with reactive hyperplasia of the epithelium. The
cornea is infiltrated with predominantly mononuclear cells (HE stained; magnification, 3200). (G) Immunohistochemical staining for CD41 cells
demonstrating predominantly subepithelial localization of CD41 cells (arrowhead) in the corresponding section of the cornea of patient 6
(hematoxylin counterstained; magnification, 3200).
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of the 12 patients studied. Intracorneal HSV-specific T-cell
reactivity, mainly HSV-type common, was observed in 9 of 12
corneas tested. These data indicate that T cells specific for the
triggering virus infiltrate corneas of HSK patients. In patient 8,
however, the HSV-specific response was solely directed to
HSV-2. Possibly, the determinants recognized by these T cells
are HSV-type common and are not efficiently processed and
presented in HSV-1– compared with HSV-2–infected BLCLs.
Surprisingly, HSV-reactive T cells could also be detected in
TCLs of patients in a quiescent phase, treated with steroids,
and even from HSV DNA–negative corneas. These data suggest
that HSV-specific T cells can reside for longer periods of time
and, even under steroid treatment, in corneas of patients with
HSV-induced stromal keratitis.
In contrast to corneas of patients with necrotizing stromal
keratitis17 (Fig. 2E), murine HSK corneas are devoid of HSV
antigens.1,2 Nonetheless, HSV-specific T cells have been dem-
onstrated in whole-eye cell suspensions of mice with fulminate
HSK.3 Similarly, in 8 of the 9 HSK patients, from which intra-
corneal HSV-specific T cells were recovered, the corneas were
devoid of HSV antigens. On infiltration of the cornea, these
HSV-specific T cells may have been activated by viral peptides
retained by corneal cells like Longerhans Cell (LC), or the
amount of HSV antigens in the corneas is too low to be
detected by immunohistochemistry. Alternatively, potential
keratogenic CD41 T cells infiltrating HSV-infected corneas may
be activated nonspecifically (e.g., by cytokine-mediated by-
stander activation)18 or activated on recognition of seques-
tered corneal autoantigens unmasked or altered after HSV rep-
lication in the cornea.2 Recently, studies performed in the
murine HSK model have provided evidence for the latter as-
sumption.7,8 HSK could be induced in nude mice after adop-
tive transfer of HSV-1 UL6 peptide–specific CD41 T cells8
cross-reacting with an unknown corneal protein.7 We analyzed
whether this type of autoimmunity may play a role in human
HSK. In none of the TCLs generated from corneas of any of the
HSK patients studied here, reactivity to HSV-1 UL6 or a HuSoCo
protein extract could be demonstrated. Stimulation of the
intracorneal TCLs with PHA-L resulted in high proliferative
responses, indicating that this is not due to a low viability of
the TCLs tested (Table 2). The lack of reactivity toward HSV-1
UL6, harboring the cross-reactive epitope, is not surprising
given the constraints of major histocompatibility complex al-
lele-specific peptide binding.19 In the case of the HuSoCo
protein extract, the negative results could be due to a true lack
of autoreactive T cells or an inappropriate corneal antigen
preparation used. The putative corneal autoantigen could be
located in the buffer-insoluble part of the human cornea ex-
tract, it may be genetically polymorph or the intracorneal
autoreactive T-cell responses are mediated by CD81 T cells.
Given the nature of the HuCoSo protein extract and the type of
assay used (i.e., exogenous antigen preparation in a T-cell
proliferation assay), the potential role of CD81 cornea autoan-
tigen–specific T cells in HSK could not be addressed. In the
HSK mouse model, the keratogenic T-cell clone recognized an
unknown Tris–buffer soluble cornea-specific antigen7and was
able to induce the disease in HSK-resistant mice, arguing
against genetic polymorphism of the autoantigen. The HuSoCo
protein extract used here, obtained from 12 human cornea
buttons and similarly generated as described in the murine HSK
study,7,12 was a heterogeneous protein preparation in which
the major soluble cornea protein BCP5412 was predominantly
present (sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis analysis; data not shown). Positive peripheral blood
T-cell responses, using similar concentrations of an equivalent
HuSoCo protein extract or purified BCP54, have been obtained
in patients with inflammatory corneal diseases.20,21 These data
suggest that the HuSoCo protein extract used in the present
study may be considered immunogenic. Although not formally
excluded, the lack of intracorneal T-cell reactivity to HSV-1 UL6
and human corneal antigens does not support the hypothesis
that human HSK is an HSV-induced autoimmune disease. The
cloning and identification of the putative HSK-related murine
cornea autoantigen, and its human homologue will be needed
to further address the validity of the molecular mimicry hy-
pothesis at the single antigen level.
In conclusion, the present study demonstrates T cells
specific for the triggering virus in the corneas of the majority of
the 12 HSK patients studied. On antigenic stimulation, the
cornea-derived HSV-specific T cells from HSK patients secrete
TABLE 2. Phenotype and Antigen-Specific Proliferative Responses of Cornea-Derived TCLs from HSK Patients
Patient
No.
% of Cells with
Phenotype [3H]-Thymidine Incorporation, cpm*
CD31 CD41 CD81
BLCL/
Mock
BLCL/
HSV-1
BLCL/
HSV-2
BLCL/
VV-WT
BLCL/
rVV-UL6
PBMC/
Medium
PBMC/
HuSoCo PHA-L
1 92 68 23 1,260 6 122 8,749 6 659 ND ND ND 131 6 34 112 6 52 21,026 6 4809
2 98 84 11 19 6 9 9,158 6 584 7,777 6 109 29 6 6 24 6 7 370 6 54 442 6 77 14,233 6 374
3 97 67 29 616 6 133 1,173 6 116 1,576 6 98 119 6 15 144 6 83 83 6 26 155 6 51 27,059 6 5168
4 99 76 24 161 6 61 1,253 6 121 1,701 6 97 ND ND 292 6 37 243 6 13 32,448 6 4433
5 96 29 69 67 6 26 455 6 69 191 6 19 27 6 3 48 6 5 50 6 7 49 6 11 37,037 6 559
6 96 46 49 2,085 6 308 29,125 6 3088 9,235 6 780 ND ND 824 6 55 913 6 86 27,309 6 1237
7 99 97 3 123 6 33 103 6 2 128 6 21 131 6 21 163 6 32 173 6 33 123 6 19 15,399 6 696
8 98 34 63 160 6 78 332 6 23 825 6 39 ND ND 131 6 41 112 6 42 35,183 6 809
9 99 98 ,1 109 6 15 1,426 6 159 4,014 6 371 ND ND 80 6 58 130 6 22 14,843 6 1762
10 98 54 32 387 6 72 14,298 6 1122 1,518 6 294 104 6 16 113 6 28 374 6 103 140 6 32 31,829 6 968
11 96 53 43 90 6 16 147 6 29 170 6 21 55 6 15 63 6 16 631 6 57 290 6 67 26,632 6 643
12 ND ND ND 699 6 172 6,718 6 434 7,264 6 360 857 6 93 778 6 73 666 6 103 2,424 6 232 32,449 6 1023
* T cells were incubated with autologous BLCLs infected with HSV-1 or -2, VV-WT, or VV expressing HSV-1 protein UL6. Alternatively, T cells
were cultured with autologous PBMCs in the presence of HuSoCo, medium or PHA-L (1 mg/ml) as negative and positive controls. Results using 50
mg/ml HuSoCo are presented. Data are expressed as mean cpm 6 SD of triplicate cultures. ND, not done.
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both interferon gamma (IFN-g) and interleukin 2 (IL-2)9 (data
not shown). In the mouse HSK model, both cytokines have
been shown to be pathologic in the cornea of HSV-1–infected
mice.4,5,22 IFN-g has been shown to facilitate migration of
PMNs from the blood into the cornea, and on activation by IL-2,
and perhaps IFN-g secretes proteolytic enzymes that contrib-
ute to destruction of the cornea.1,2,23 We hypothesize that
HSV-specific T cells have an important role in the local immu-
nopathogenesis of HSK in humans. On entry into the cornea
they are activated by HSV-infected corneal cells or by viral
peptides retained by corneal cells like LC corneal cells and,
subsequently, initiate a cytokine-mediated immunopathogenic
response in the cornea.
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